Pharmaceutical Stocks List

Pharmaceutical Stocks Recent News

Date Stock Title
May 3 ANIP Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
May 2 ANIP Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
May 2 ALPN Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
May 2 SXTP 60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
May 2 ALVO Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 2 ABBV The top pharmaceutical companies by R&D expenditure
May 1 ANIP ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
May 1 ANIP GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
May 1 ANIP How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
Apr 30 ALVO Alvotech to produce Humira biosimilar for Cigna's Quallent
Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Apr 30 ACRS Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30 ALVO U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags